Scarica l'app Stockscreener
0.6073
11.33%
0.0618
Dopo l'orario di chiusura:
.56
-0.0473
-7.79%
Precedente Chiudi:
$0.5455
Aprire:
$0.53
Volume 24 ore:
37.80M
Relative Volume:
6.70
Capitalizzazione di mercato:
$18.39M
Reddito:
-
Utile/perdita netta:
$-29.77M
Rapporto P/E:
-0.0397
EPS:
-15.2954
Flusso di cassa netto:
$-24.23M
1 W Prestazione:
+8.35%
1M Prestazione:
+7.11%
6M Prestazione:
-52.18%
1 anno Prestazione:
-75.41%
Intervallo 1D:
$0.4901
$0.62
Intervallo di 1 settimana:
$0.4901
$0.62
Portata 52W:
$0.25
$3.6499
Moleculin Biotech Inc Stock (MBRX) Company Profile
Nome
Moleculin Biotech Inc
Settore
Industria
Telefono
713-300-5160
Indirizzo
5300 MEMORIAL DRIVE, HOUSTON, TX
Confronta MBRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MBRX
Moleculin Biotech Inc
|
0.6073 | 16.48M | 0 | -29.77M | -24.23M | -15.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Moleculin Biotech Inc Stock (MBRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-09 | Ripresa | H.C. Wainwright | Buy |
| 2025-02-12 | Downgrade | Maxim Group | Buy → Hold |
| 2022-07-18 | Ripresa | Oppenheimer | Outperform |
Moleculin Biotech Inc Borsa (MBRX) Ultime notizie
Moleculin Biotech Completes Promising Annamycin Trial - MSN
How to manage a losing position in Moleculin Biotech Inc.2025 Market Overview & Community Consensus Picks - Newser
Has Moleculin Biotech Inc. found a price floorEntry Point & AI Driven Stock Reports - Newser
Is Moleculin Biotech Inc. stock bottoming outJuly 2025 Retail & Real-Time Chart Pattern Alerts - Newser
Statistical indicators supporting Moleculin Biotech Inc.’s strengthJuly 2025 Final Week & Real-Time Volume Spike Alerts - Newser
Analyzing recovery setups for Moleculin Biotech Inc. investorsEarnings Risk Summary & Risk Controlled Swing Trade Alerts - Newser
Moleculin Biotech IncCompletion of its Phase 1b/2 (MB-106) clinical trial evaluating Annamycin in combination with Cytarabine - MarketScreener
Moleculin Issues New Positive AML Overall Survival Data: - GlobeNewswire
Triple Survival Rate: Moleculin's AML Drug Achieves 15-Month Survival vs. 4-6 Month Standard in Cancer Trial - Stock Titan
Trend analysis for Moleculin Biotech Inc. this week2025 Stock Rankings & Free Verified High Yield Trade Plans - Newser
Using R and stats models for Moleculin Biotech Inc. forecastingBear Alert & Technical Analysis for Trade Confirmation - Newser
Heatmap analysis for Moleculin Biotech Inc. and competitors2025 Analyst Calls & Capital Protection Trading Alerts - Newser
What earnings revisions data tells us about Moleculin Biotech Inc.2025 Market Outlook & Weekly High Momentum Picks - Newser
Risk vs reward if holding onto Moleculin Biotech Inc.July 2025 Drop Watch & Fast Moving Trade Plans - Newser
Will Moleculin Biotech Inc. stock recover after recent dropEarnings Performance Report & Weekly High Return Stock Opportunities - Newser
Will Moleculin Biotech Inc. bounce back from current supportEarnings Overview Summary & Risk Managed Trade Strategies - Newser
Volume spikes in Moleculin Biotech Inc. stock – what they meanJuly 2025 Retail & Risk Controlled Stock Pick Alerts - Newser
Does Moleculin Biotech Inc. fit your quant trading modelJuly 2025 Summary & Precise Swing Trade Entry Alerts - Newser
Can Moleculin Biotech Inc. recover in the next quarterPortfolio Risk Summary & Long-Term Growth Plans - Newser
Is Moleculin Biotech Inc. stock reversal real or fakeJuly 2025 PostEarnings & Community Verified Trade Signals - Newser
Quant Funds Rotate Into Moleculin Biotech Inc. StockQuarterly Market Summary & Verified High Yield Trade Plans - beatles.ru
What’s the outlook for Moleculin Biotech Inc.’s sectorPortfolio Performance Report & Risk Controlled Stock Pick Alerts - theviewers.co.kr
Is Moleculin Biotech Inc. forming a breakout patternTake Profit & Fast Momentum Stock Entry Tips - theviewers.co.kr
Gains Recap: Is Moleculin Biotech Inc. stock undervalued right nowTrend Reversal & Trade Opportunity Analysis Reports - theviewers.co.kr
Is Moleculin Biotech Inc. stock a hidden gemJuly 2025 Weekly Recap & Advanced Swing Trade Entry Alerts - 더경남뉴스
Trend Reversal Possible in Moleculin Biotech Inc. Charts Indicate2025 Dividend Review & Free Safe Entry Trade Signal Reports - kangso.co.kr
Traders Consider Averaging Down in Moleculin Biotech Inc.Weekly Stock Report & AI Forecasted Entry and Exit Points - beatles.ru
Using Bollinger Bands to evaluate Moleculin Biotech Inc.Market Growth Report & Safe Capital Growth Tips - Newser
Combining price and volume data for Moleculin Biotech Inc.Weekly Profit Analysis & High Conviction Buy Zone Alerts - Newser
What’s the recovery path for long term holders of Moleculin Biotech Inc.Weekly Gains Report & Community Verified Trade Alerts - Newser
Moleculin Biotech Releases New Corporate Presentation - TipRanks
Custom watchlist performance reports with Moleculin Biotech Inc.July 2025 Snapshot & Capital Efficient Trading Techniques - Newser
Using RSI to spot recovery in Moleculin Biotech Inc.July 2025 Earnings & Trade Opportunity Analysis Reports - Newser
Has Moleculin Biotech Inc. Stock Ever Crashed Historical Volatility ReviewShare Buyback & Consistent Income Trade Recommendations - Newser
HC Wainwright Has Positive Estimate for MBRX Q3 Earnings - Defense World
How to use Fibonacci retracement on Moleculin Biotech Inc.Market Risk Summary & Safe Entry Trade Signal Reports - Newser
Using AI based signals to follow Moleculin Biotech Inc.2025 Top Decliners & Long-Term Safe Investment Plans - Newser
Applying Elliott Wave Theory to Moleculin Biotech Inc.2025 Institutional Moves & Weekly Breakout Opportunity Watchlist - Newser
Moleculin Biotech Inc Azioni (MBRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.98%
8.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):